|
SSRP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.466990E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.028360E-02 |
| Normal-vs-Stage2 |
2.988400E-01 |
| Normal-vs-Stage3 |
9.700400E-01 |
| Normal-vs-Stage4 |
1.422230E-01 |
| Stage1-vs-Stage2 |
5.041600E-04 |
| Stage1-vs-Stage3 |
3.576300E-03 |
| Stage1-vs-Stage4 |
5.359600E-01 |
| Stage2-vs-Stage3 |
3.064600E-01 |
| Stage2-vs-Stage4 |
2.823700E-02 |
| Stage3-vs-Stage4 |
1.377750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.980200E-02 |
| Normal-vs-AfricanAmerican |
8.862200E-01 |
| Normal-vs-Asian |
5.670000E-01 |
| Caucasian-vs-AfricanAmerican |
1.070380E-01 |
| Caucasian-vs-Asian |
9.559200E-01 |
| AfricanAmerican-vs-Asian |
6.320400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.421020E-01 |
| Normal-vs-Female |
2.110600E-01 |
| Male-vs-Female |
7.813000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.361200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.127050E-01 |
| Normal-vs-Age(61-80Yrs) |
1.417760E-01 |
| Normal-vs-Age(81-100Yrs) |
3.812000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.259000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.913200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.487400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.452000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.213600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.215700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.899300E-03 |
| Normal-vs-Grade 2 |
8.642300E-03 |
| Normal-vs-Grade 3 |
6.746800E-01 |
| Normal-vs-Grade 4 |
6.754000E-01 |
| Grade 1-vs-Grade 2 |
1.988410E-01 |
| Grade 1-vs-Grade 3 |
3.432300E-02 |
| Grade 1-vs-Grade 4 |
5.935700E-02 |
| Grade 2-vs-Grade 3 |
4.222700E-03 |
| Grade 2-vs-Grade 4 |
4.506500E-02 |
| Grade 3-vs-Grade 4 |
9.399800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.961820E-03 |
| Normal-vs-ccB subtype |
7.716400E-01 |
| ccA subtype-vs-ccB subtype |
1.717590E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.810400E-01 |
| Normal-vs-N1 |
5.802600E-01 |
| N0-vs-N1 |
9.822400E-01 |
|
|
